VEA
PHVS icon

Virtus ETF Advisers’s Pharvaris PHVS Stock Holding History

Virtus ETF Advisers’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,738
Closed -$71.7K – 693
2024
Q4 		$71.7K Sell
3,738
-1,351
-27% -$27.8K 0.03% 359
2024
Q3 		$94.2K Buy
5,089
+88
+2% +$1.61K 0.04% 385
2024
Q2 		$94K Buy
+5,001
New +$102K 0.05% 340

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Virtus ETF Advisers's PHVS Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Pharvaris (PHVS) in Q1 2025, closing a stake of 3,738 shares — an estimated $71.7K sold.

Virtus ETF Advisers first reported a position in PHVS in Q2 2024 and held it in 3 quarters. The position peaked at $94.2K in Q3 2024. 52 funds tracked by Wall St. Rank hold PHVS as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Pharvaris position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 3,738 Pharvaris shares in Q1 2025, an estimated $71.7K.
  • Virtus ETF Advisers first reported a position in Pharvaris in Q2 2024 and held it in 3 quarters.
  • Virtus ETF Advisers's Pharvaris position peaked at $94.2K in Q3 2024.
  • 52 funds tracked by Wall St. Rank held Pharvaris as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.